Page last updated: 2024-10-24

positive regulation of voltage-gated chloride channel activity

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of voltage-gated chloride channel activity. [GO_REF:0000059, GOC:als, GOC:TermGenie, PMID:22006324]

Positive regulation of voltage-gated chloride channel activity is a biological process that increases the activity of voltage-gated chloride channels. These channels are transmembrane proteins that open and close in response to changes in the electrical potential across the cell membrane. When open, they allow chloride ions to flow across the membrane, contributing to the regulation of cell excitability, membrane potential, and cell volume. The process of positive regulation involves a variety of molecular mechanisms, including:

- **Binding of ligands:** Certain molecules can bind to voltage-gated chloride channels and increase their activity. For example, some neurotransmitters or hormones can activate these channels.
- **Phosphorylation:** Enzymes called kinases can add phosphate groups to specific amino acids within the channel proteins. This modification can alter the channel's conformation and increase its activity.
- **Protein-protein interactions:** Some proteins can interact with voltage-gated chloride channels and influence their activity. For instance, scaffolding proteins may hold channels together in specific locations or enhance their interactions with other signaling molecules.
- **Changes in membrane lipid composition:** The lipid environment surrounding the channel can influence its activity. For example, changes in the fluidity of the membrane can affect channel opening and closing.

The regulation of voltage-gated chloride channel activity is essential for a wide range of physiological functions. These channels play crucial roles in:

- **Nervous system:** Regulating neuronal excitability and synaptic transmission.
- **Muscle contraction:** Modulating muscle fiber excitability.
- **Epithelial transport:** Controlling fluid and electrolyte balance in tissues.
- **Cell volume regulation:** Maintaining the proper size and shape of cells.
- **Immune response:** Regulating the activity of immune cells.

Dysregulation of voltage-gated chloride channel activity can contribute to various diseases, including epilepsy, muscular dystrophy, cystic fibrosis, and cancer. Understanding the molecular mechanisms underlying this process is crucial for developing effective treatments for these disorders.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Cystic fibrosis transmembrane conductance regulatorA cystic fibrosis transmembrane conductance regulator that is encoded in the genome of human. [PRO:CNA, UniProtKB:P13569]Homo sapiens (human)

Compounds (13)

CompoundDefinitionClassesRoles
glyburideglyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.

Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
monochlorobenzenes;
N-sulfonylurea
anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
methyl anthranilatemethyl anthranilate : A benzoate ester that is the methyl ester of anthranilic acid.benzoate esterflavouring agent;
metabolite
telmisartantelmisartan : A member of the class of benzimidazoles used widely in the treatment of hypertension.

Telmisartan: A biphenyl compound and benzimidazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION.
benzimidazoles;
biphenyls;
carboxybiphenyl
angiotensin receptor antagonist;
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
environmental contaminant;
xenobiotic
tadalafilbenzodioxoles;
pyrazinopyridoindole
EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
7-n-butyl-6-(4'-hydroxyphenyl)-5h-pyrrolo(2,3b)pyrazine
3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone3-((3-trifluoromethyl)phenyl)-5-((3-carboxyphenyl)methylene)-2-thioxo-4-thiazolidinone: a cystic fibrosis transmembrane conductance regulator inhibitor; structure in first source
uccf-029organic heterotricyclic compound;
organooxygen compound
quercetin7-hydroxyflavonol;
pentahydroxyflavone
antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
apigeninChamomile: Common name for several daisy-like plants (MATRICARIA; TRIPLEUROSPERMUM; ANTHEMIS; CHAMAEMELUM) native to Europe and Western Asia, now naturalized in the United States and Australia.trihydroxyflavoneantineoplastic agent;
metabolite
rutinHydroxyethylrutoside: Monohydroxyethyl derivative of rutin. Peripheral circulation stimulant used in treatment of venous disorders.disaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone
antioxidant;
metabolite
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
vx-770ivacaftor : An aromatic amide obtained by formal condensation of the carboxy group of 4-oxo-1,4-dihydroquinoline-3-carboxylic acid with the amino group of 5-amino-2,4-di-tert-butylphenol. Used for the treatment of cystic fibrosis.

ivacaftor: a CFTR potentiator; structure in first source
aromatic amide;
monocarboxylic acid amide;
phenols;
quinolone
CFTR potentiator;
orphan drug
lumacaftorlumacaftor : An aromatic amide obtained by formal condensation of the carboxy group of 1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropane-1-carboxylic acid with the aromatic amino group of 3-(6-amino-3-methylpyridin-2-yl)benzoic acid. Used for the treatment of cystic fibrosis.

lumacaftor: a corrector of CF transmembrane conductance regulator (CTFR); structure in first source
aromatic amide;
benzodioxoles;
benzoic acids;
cyclopropanes;
organofluorine compound;
pyridines
CFTR potentiator;
orphan drug